1. Home
  2. ARDX vs CBL Comparison

ARDX vs CBL Comparison

Compare ARDX & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • CBL
  • Stock Information
  • Founded
  • ARDX 2007
  • CBL 1978
  • Country
  • ARDX United States
  • CBL United States
  • Employees
  • ARDX N/A
  • CBL N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • CBL Real Estate Investment Trusts
  • Sector
  • ARDX Health Care
  • CBL Real Estate
  • Exchange
  • ARDX Nasdaq
  • CBL Nasdaq
  • Market Cap
  • ARDX 882.9M
  • CBL 777.7M
  • IPO Year
  • ARDX 2014
  • CBL 1993
  • Fundamental
  • Price
  • ARDX $5.55
  • CBL $30.28
  • Analyst Decision
  • ARDX Strong Buy
  • CBL
  • Analyst Count
  • ARDX 9
  • CBL 0
  • Target Price
  • ARDX $10.50
  • CBL N/A
  • AVG Volume (30 Days)
  • ARDX 3.1M
  • CBL 110.7K
  • Earning Date
  • ARDX 10-30-2025
  • CBL 11-10-2025
  • Dividend Yield
  • ARDX N/A
  • CBL 5.97%
  • EPS Growth
  • ARDX N/A
  • CBL 128.05
  • EPS
  • ARDX N/A
  • CBL 2.10
  • Revenue
  • ARDX $386,146,000.00
  • CBL $539,452,000.00
  • Revenue This Year
  • ARDX $17.79
  • CBL N/A
  • Revenue Next Year
  • ARDX $27.82
  • CBL N/A
  • P/E Ratio
  • ARDX N/A
  • CBL $14.45
  • Revenue Growth
  • ARDX 83.88
  • CBL 2.20
  • 52 Week Low
  • ARDX $3.21
  • CBL $21.10
  • 52 Week High
  • ARDX $7.04
  • CBL $33.54
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 34.81
  • CBL 47.09
  • Support Level
  • ARDX $5.49
  • CBL $29.79
  • Resistance Level
  • ARDX $6.78
  • CBL $30.50
  • Average True Range (ATR)
  • ARDX 0.21
  • CBL 0.59
  • MACD
  • ARDX -0.15
  • CBL -0.26
  • Stochastic Oscillator
  • ARDX 5.02
  • CBL 21.46

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

Share on Social Networks: